Optimal Design in Population Kinetic Experiments by Set-Valued Methods.
- Published in:
- AAPS Journal, 2011, v. 13, n. 4, p. 495, doi. 10.1208/s12248-011-9291-8
- By:
- Publication type:
- Article
Works matching IS 15507416 AND DT 2011 AND VI 13 AND IP 4
Results: 16
1
2
Bayesian Quantitative Disease-Drug-Trial Models for Parkinson's Disease to Guide Early Drug Development.
- Published in:
- AAPS Journal, 2011, v. 13, n. 4, p. 508, doi. 10.1208/s12248-011-9293-6
- By:
- Publication type:
- Article
3
Bilirubin-A Potential Marker of Drug Exposure in Atazanavir-Based Antiretroviral Therapy.
- Published in:
- AAPS Journal, 2011, v. 13, n. 4, p. 598, doi. 10.1208/s12248-011-9299-0
- By:
- Publication type:
- Article
4
Epigenetic CpG Demethylation of the Promoter and Reactivation of the Expression of Neurog1 by Curcumin in Prostate LNCaP Cells.
- Published in:
- AAPS Journal, 2011, v. 13, n. 4, p. 606, doi. 10.1208/s12248-011-9300-y
- By:
- Publication type:
- Article
5
Differential Metabolism of Organic Nitrates by Aldehyde Dehydrogenase 1a1 and 2: Substrate Selectivity, Enzyme Inactivation, and Active Cysteine Sites.
- Published in:
- AAPS Journal, 2011, v. 13, n. 4, p. 548, doi. 10.1208/s12248-011-9295-4
- By:
- Publication type:
- Article
6
Quantitative PK-PD Model-Based Translational Pharmacology of a Novel Kappa Opioid Receptor Antagonist Between Rats and Humans.
- Published in:
- AAPS Journal, 2011, v. 13, n. 4, p. 565, doi. 10.1208/s12248-011-9296-3
- By:
- Publication type:
- Article
7
Factors Influencing the Use and Interpretation of Animal Models in the Development of Parenteral Drug Delivery Systems.
- Published in:
- AAPS Journal, 2011, v. 13, n. 4, p. 632, doi. 10.1208/s12248-011-9303-8
- By:
- Publication type:
- Article
8
Relationships between Liposome Properties, Cell Membrane Binding, Intracellular Processing, and Intracellular Bioavailability.
- Published in:
- AAPS Journal, 2011, v. 13, n. 4, p. 585, doi. 10.1208/s12248-011-9298-1
- By:
- Publication type:
- Article
9
BDDCS Applied to Over 900 Drugs.
- Published in:
- AAPS Journal, 2011, v. 13, n. 4, p. 519, doi. 10.1208/s12248-011-9290-9
- By:
- Publication type:
- Article
10
Harmonization of Regulatory Approaches for Evaluating Therapeutic Equivalence and Interchangeability of Multisource Drug Products: Workshop Summary Report.
- Published in:
- 2011
- By:
- Publication type:
- Report
11
Biomarkers for Drug-Induced Renal Damage and Nephrotoxicity-An Overview for Applied Toxicology.
- Published in:
- AAPS Journal, 2011, v. 13, n. 4, p. 615, doi. 10.1208/s12248-011-9301-x
- By:
- Publication type:
- Article
12
Pharmacodynamic Model of Sodium-Glucose Transporter 2 (SGLT2) Inhibition: Implications for Quantitative Translational Pharmacology.
- Published in:
- AAPS Journal, 2011, v. 13, n. 4, p. 576, doi. 10.1208/s12248-011-9297-2
- By:
- Publication type:
- Article
13
Erratum to: Modeling the Effects of Vaccination and Treatment on Pandemic Influenza.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
14
Comparative Performance of Cell Life Span and Cell Transit Models for Describing Erythropoietic Drug Effects.
- Published in:
- AAPS Journal, 2011, v. 13, n. 4, p. 650, doi. 10.1208/s12248-011-9302-9
- By:
- Publication type:
- Article
15
Holford NHG and Sheiner LB 'Understanding the Dose-Effect Relationship-Clinical Application of Pharmacokinetic-Pharmacodynamic Models', Clin Pharmacokin 6:429-453 (1981)-The Backstory.
- Published in:
- AAPS Journal, 2011, v. 13, n. 4, p. 662, doi. 10.1208/s12248-011-9306-5
- By:
- Publication type:
- Article
16
Population Pharmacokinetics of Telapristone (CDB-4124) and its Active Monodemethylated Metabolite CDB-4453, with a Mixture Model for Total Clearance.
- Published in:
- AAPS Journal, 2011, v. 13, n. 4, p. 665, doi. 10.1208/s12248-011-9304-7
- By:
- Publication type:
- Article